Hydrazone-schiff base derivatives of 4-(tert-butyl)benzoic acid as potent enzyme inhibitors: In vitro α-amylase, α-glucosidase, tyrosinase inhibition and computational studies
Imen Zghab, Sajjad Ahmad, Imtiaz Ahmad, Aftab Alam, Shah Mulk, Zainab Aziz, Masroor Kamal, Ferjeni Zouidi · 2026
Read Hydrazone-schiff base derivatives of 4-(tert-butyl)benzoic acid as potent enzyme inhibitors: In vitro α-amylase, α-glucosidase, tyrosinase inhibition and computational studies by Imen Zghab, Sajjad Ahmad, Imtiaz Ahmad, Aftab Alam, Shah Mulk, Zainab Aziz, Masroor Kamal, Ferjeni Zouidi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0348140.txt.
Description
Imen Zghab and co-workers create a family of new molecules and test whether they can block enzymes tied to blood sugar and skin darkening. Blocking the two sugar enzymes could help diabetes care, while blocking the third interests cosmetics. Their 2026 study builds the compounds from a simple acid base and checks them in lab dishes against standard drugs.
One compound blocked both sugar enzymes far more strongly than the standard diabetes drug used for comparison. A sister compound led on the skin enzyme, beating a common reference agent. Computer models of how the molecules dock into the enzymes matched the dish results. The pair stand out as starting points for medicines that do several jobs at once.
Catalog record
| CREATOR | Imen Zghab, Sajjad Ahmad, Imtiaz Ahmad, Aftab Alam, Shah Mulk, Zainab Aziz, Masroor Kamal, Ferjeni Zouidi |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 70665 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |